Deepak L. Bhatt, MD, MPH, of the Interventional Cardiovascular Program at Brigham, and colleagues, recently performed a systematic review and meta-analysis and report that prescription EPA treatment, and not EPA+DHA supplementation, is associated with reductions in cardiovascular mortality and related outcomes.

Marcelo F. DiCarli, MD, of the Cardiovascular Imaging Program at the Brigham, and Wunan Zhou, MD, MPH, at the NIH, and colleagues report that impaired myocardial blood flow reserve is an early marker of adverse myocardial characteristics and can identify patients who might benefit from aortic valve replacement.

Tsuyoshi Kaneko, MD, of the Heart & Vascular Center at Brigham, served as the first author of the initial analysis of CUTTING-EDGE data. Two key findings are that 93% of patients required MV replacement and one-year cumulative mortality for the entire cohort was 24%.

Sameer Hirji, MD, MPH, and Tsuyoshi Kaneko, MD, of the Division of Cardiac Surgery at the Brigham, and colleagues summarize the revised recommendations about caring for patients with secondary mitral regurgitation now that transcatheter edge-to-edge mitral repair has emerged as a treatment option.

William Henry Sauer, MD, section chief for Brigham’s Cardiac Arrhythmia Service, discusses how the hospital’s expert cardiologists are correcting heart rhythm disorders using a variety of electrophysiology-based treatments to relieve patients’ suffering, improve their quality of life and save lives.